Biopsychosocial approach to delirium treatment in patients with COVID-19
Despite the success of treatment in a 46-year-old female patient treated for the diagnosis of COVID-19, the developing delirium picture does not benefit from the agents given pharmacologically. With the careful approach and communication skills of the nurse, the cause of the patient’s agitation was understood and the physician used the initiative and the patient’s husband was taken to the patient room as an attendant. With the effect of the biopsychosocial approach, the patient’s delirium picture rapidly regressed. This approach model, which is the basis of physician and nursing practices, provides benefits in every step of the health services.
- Delirium: diagnosis, prevention and management. NICE clinical guideline. [cited 2015 Feb 13]. http://www. nice.org.uk/guidance/ cg103 adresinden 05.04.2020 tarihinde erişilmiştir.
- Hughes CG, Brummel NE, Vasilevskis EE, Girard TD, et al. Future directions of delirium research and management. Best Pract Res Clin Anaesthesiol 2012;26:395–405.
- Irwin R, Rippe JM. Irwin ve Rippe’nin Yoğun Bakım Tıbbı Cilt 2. Çev. eds. Tulunay M, Cuhruk H. 6. Baskı. Ankara, Güneş Kitabevleri, 2014.
- Neufeld KJ, Yue J, Robinson TN, Inouye SK, et al. Antipsychotic Medication for Prevention and Treatment of Delirium in Hospitalized Adults: A Systematic Review and Meta-Analysis. J Am Geriatr Soc 2016;64:705–14.